ProVerum
Company Details
Status: Private
Employees: 11-50
Location:
Trinity Translational Medicine Institute,Trinity Centre for Health Sciences, St James’ Hospital, Dublin, Ireland Dublin 8, IE
Type:
sample
Technology:
sample
About: ProVerum Medical is a Dublin-based medical device company founded in 2016. The company specializes in minimally invasive solutions for benign prostatic hyperplasia (BPH), focusing on developing technologies that address lower urinary tract symptoms caused by prostate enlargement.
Their primary product, the ProVee System, features a nitinol expander designed to reshape the enlarged prostate and alleviate urinary obstruction. This system is deployed through a low-profile, flexible delivery method that integrates imaging, making it compatible with standard office-based endoscopes. The procedure is minimally invasive and can be performed under local anesthesia, offering a patient-friendly alternative to traditional surgery. ProVerum holds eight patents, including one granted in 2023 for a device that deploys expandable implants targeting BPH and urinary system disorders.
The company has raised a total of $38.58 million in funding, including a €30 million Series A round in 2022. ProVerum is currently conducting the ProVIDE study to evaluate the safety and efficacy of the ProVee system, which completed enrollment in March 2024.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
ProVerum | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.